An introduction to this year’s C the Whole Story theme When we talk about “culturally safe” hepatitis C virus (HCV) care, what do we really mean? And how can creating a culturally safe environment improve treatment outcomes for people living with HCV? These questions form the foundation of this year’s C the Whole Story Forum, […]
People living with a blood-borne virus (BBV) in Australia experience legal issues at significantly higher rates than those without and commonly face multiple and overlapping legal problems at once. These findings come from Health+Law’s Legal Needs Study, which also found the majority of participants report their most serious legal issues are linked to, or worsened by, living with a BBV. As […]
For the first time, ASHM has published an annual Global Impact Report to highlight achievements from the previous year and to serve as an update on how key projects across Asia and the Pacific are making positive change. The report can be viewed in its entirety here, but below are some of the notable highlights […]
Deadly Sex NSW 2026 Yarning about Sexual Health: Building Strength, Breaking Barriers Join AH&MRC & ASHM for the inaugural Deadly Sex NSW Forum, a two-day event in Bidjigal & Gadigal Lands (Sydney), 17 & 18 March 2026. This event offers Aboriginal and Torres Strait Islander Primary Health Care Professionals in NSW the opportunities to update their knowledge, […]
On the 6th of April 2024, ASHM Health organised a national workshop, funded by ViiV Healthcare, to convene a select group of key stakeholders from each Australian state and territory. The primary objective was to facilitate discussions around how to successfully implement the use of long-acting injectable cabotegravir (CAB-LA) as HIV PrEP throughout Australia and to identify […]
As of 9 September 2024, Australia is currently experiencing a supply shortage of medications containing tenofovir and emtricitabine, which are commonly used for HIV Pre-Exposure Prophylaxis (PrEP). Despite this shortage, pharmacists, HIV PrEP prescribers, and people using HIV PrEP should not be alarmed — shortages are expected to resolve later this year for most brands. Current impact […]
When studying the genotype of chronic hepatitis B (CHB) in the Northern Territory (NT), researchers discovered that 100% of CHB in Aboriginal and Torres Strait Islander peoples in the NT is due to the unique sub-genotype C4 , which is associated with quicker progression to liver cancer and cirrhosis. “It upped the urgency for us […]
Hepatitis C is curable in most people. Hepatitis C treatment in the form of direct-acting antiviral medicines (DAAs) can cure more than 95% of people living with hepatitis C. While the number of people living with hepatitis C is decreasing overall, the cumulative proportion of people living with hepatitis C initiating DAA treatment remains lower […]
In Australia, chronic hepatitis B disproportionately affects people born overseas. More than two-thirds of those living with the infection were born overseas or are Aboriginal and Torres Strait Islander people. It is therefore vital that hepatitis B programs, services and care are culturally appropriate and safe. If Australia is to reach its hepatitis B treatment […]
Presenting on the big stage at a conference can be a major moment in your career. It will expose your work to a national and international audience, and help others learn from what you’ve done. Getting there all starts with writing an engaging abstract submission which captures your work and gets the abstract selection panel […]
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2024 ASHM